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Sex Med 2Introduction: In cardiac patients with implantable cardioverter deﬁbrillator (ICD), sexual function is sparsely
described.
Aim: To determine the prevalence and distribution of sexual dysfunction, and to describe whether primary or
secondary prophylactic ICD indication and antitachycardia pacing (ATP) or shock is associated with sexual
function.
Methods: A cross-sectional survey of men with an implanted ICD was conducted at 2 university hospitals
in Denmark. Inclusion criteria were men over the age of 18 with an ICD. Exclusion criterion was no
partner.
Main Outcome Measure: Sexual function was assessed by the International Index of Erectile Function
questionnaire and data on implantation indication (primary/secondary prevention) and therapy such as ATP and
shock (both appropriate and inappropriate) was obtained from the Danish ICD Register.
Results: Data from 415 questionnaires were analyzed (response rate 50.2%). Patients had a mean age of
63.9±12.1 years. Erectile dysfunction (ED) was present in 70% of patients, orgasmic dysfunction was
present in 57.9% of patients, 82.8% had reduced sexual desire, 85.8% had intercourse satisfaction prob-
lems, and 76.9% experienced overall satisfaction problems (non-validated metric except for ED). Patients
with an ICD on primary prophylactic indication had more sexual dysfunction and ED compared with
patients with an ICD on secondary prophylactic indication. ATP therapy, but not shock, was associated
with more ED.
Conclusion: Sexual dysfunction is common in patients with ICD and is not limited to ED, but also orgasmic
function, desire, intercourse, and overall satisfaction are affected. Primary prophylactic ICD indication and ATP,
but not shock therapy, is associated with compromised sexual function. Palm P, Zwisler A-D, Svendsen JH.
Compromised Sexual Health Among Male Patients With Implantable Cardioverter Deﬁbrillator: A Cross-
Sectional Questionnaire Study. Sex Med 2019;7:169e176.
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170 Palm et alINTRODUCTION
Being able to function sexually is an important aspect of many
peoples’ lives and sexual dysfunctions have a negative impact on
quality of life and well-being.1e3 In cardiac patients treated with
implantable cardioverter deﬁbrillators (ICD), a device that
detects and treats abnormal ventricular tachyarrhythmias by
antitachycardia pacing (ATP) or high voltage shock, sexual
function is sparsely described and further information is war-
ranted. Indication for the ICD can be divided into primary
prophylactic, in which patients have not previously suffered from
cardiac arrest, but are expected to have a high risk of life-
threatening arrhythmias vs secondary, in which patients have
previously suffered from a cardiac arrest. Shocks can be divided
into appropriate, in which the ICD provides a shock to a malign
ventricular arrhythmia (the intended function), or inappropriate,
in which the ICD ﬁres when people are awake, either because of
a technical error or a benign arrhythmia. Inappropriate shocks
are often experienced as storms of shock, meaning that multiple
shocks appear.Background
Male sexual dysfunction is deﬁned as problems in relation to
erectile dysfunction (ED), desire, orgasm, or ejaculation.4 A
common sexual disorder in cardiovascular disease patients is ED,
deﬁned as the inability to achieve and maintain an erection that
enables satisfying sexual activity.4 The underlying mechanism is
often pathogenically related to cardiovascular disease, but may
also be related to psychological issues or a side effect from
medication.5,6 ED is highly associated with age.7 In ICD
patients, several small studies reveal long-term abstinence or a
decrease in sexual activity after the ICD implantation.8e11
Besides ED, sexual problems in ICD patients have been
described as overprotectiveness from the partner, lack of sexual
interest, fear of death if the ICD did not ﬁre, or fear of the ICD
shock therapy.10e12 Shock during sexual activity is experienced
in varying degrees, from <1% to 18%.10,11,13 Although shocks
are infrequent, fear of the ICD ﬁring during sexual activity seems
to have a more profound impact because this is experienced in
almost 30% of the included patients.10,11 Moreover, studies
show that therapy such as ATP or shock from the ICD may
predict a poor psychological outcome such as anxiety and psy-
chological distress,14e16 although they do not show if this
outcome is reﬂected on sexual function.
The majority of data on sexual health in ICD patients have all
been collected using the same questionnaire instrument, “The
sex after ICD questionnaire,” which was developed especially for
ICD patients.11 The instrument provides a thorough overview of
the speciﬁc sexual problems in an ICD population, however, it
does not possess the ability to detect trends over time and
evaluate results of an intervention. Moreover, the instrument
does not reﬂect the clinical deﬁnition of male sexual dysfunction
that allows for comparison among other diagnostic groups.
Finally, it does not cover the severity of ED.The role of primary vs secondary prophylactic indication on
psychological outcomes has been discussed previously, but no
negative impact has been established in relation to patients’
quality of life and distress,17 although secondary prophylactic
indication seems to affect partners’ level of anxiety.15 The in-
dications’ inﬂuence on sexual function has not yet been
described.
Altogether, sexual dysfunction in ICD patients is poorly
described. Therefore, the objective of this study was to determine
the prevalence and distribution of sexual dysfunction. Further-
more, we hypothesized that patients who had ICD for secondary
prophylaxis would have poorer sexual function compared with
primary prophylaxis patients, and that patients receiving therapy
or shock would have poorer sexual function.
MATERIALS AND METHODS
Study Design
This study was designed as a cross-sectional study and was
conducted as a post hoc analysis postal survey as part of the
recruitment process of the CopenHeart SF trial,18 a random-
ized controlled trial (RCT) that evaluated the effect of a
comprehensive rehabilitation program to decrease sexual
dysfunction. Patients were recruited from 2 university hospitals
in the Danish Capital Region. The sample includes male
patients with ICD.Eligibility Criteria and Recruitment
Hospital records were screened consecutively according to date
of ICD implantation in the period from March 2013 to June
2015. Inclusion criteria were men above the age of 18 with an
ICD. Exclusion criterion was not having a partner at the time of
answering the questionnaire. The following information was
extracted from the hospital records: age and implantation date, as
deﬁned by the main CopenHeart SF trial.18
Questionnaires were sent by mail to 826 patients. Participants
ﬁlled out a questionnaire concerning sexual function. All patients
provided written consent after receiving information about the
study.Data Sources
To investigate if implantation indication or therapy from the
ICD was associated with a poor sexual outcome, data on im-
plantation indication (primary/secondary prevention) and ther-
apy such as ATP and shock (both appropriate and inappropriate)
were obtained from the Danish ICD Register.19
Prevalence and distribution of sexual function was measured
by the Danish version of the International Index of Erectile
Function (IIEF).20,21 It consists of 15 items including 5 do-
mains: erectile function, orgasmic function, sexual desire, inter-
course satisfaction, and overall satisfaction. Higher scores
indicate a better function. The total IIEF-15 summary score
(minimum 5 points, maximum 75 points) is categorized asSex Med 2019;7:169e176
Figure 1. Flowchart.
Sexual dysfunction in ICD patients 171“good” (60e75), “fair” (44e59), and “poor” (5e43) as deﬁned
in a non-validated metric by Budweiser et al.22 The erectile
function domain has a cut-off score to diagnose and divide ED
into 4 levels of severity: severe erectile dysfunction score 6e10,
moderate erectile dysfunction score 11e16, moderate to mild
erectile dysfunction score 17e21, mild erectile dysfunction score
22e25, and score above 25 indicates no dysfunction. For the
other domains, a dysfunction was determined if scores were: 8 or
less for the orgasmic function domain, the sexual desire domain,
the overall satisfaction domain, and a score of 12 for the
intercourse satisfaction domain, which is a non-validated metric,
but in line with another study by Platek et al.23 The IIEF meets
psychometric criteria for test reliability and validity, and has a
high degree of sensitivity and speciﬁcity.21Study Size
The sample size has not been determined statistically, but was
alone determined by the number of questionnaires generated in
the CopenHeart SF RCT trial. Based on the already-enrolled
patients in the main trial, the number of questionnaires
distributed was 826.Statistical Methods
Data were tested for normality using the Kolmogorov-
Smirnov test. Continuous data were presented as mean scores
with corresponding SD and compared using either the Student’s
t-test or the Mann-Whitney depending on the normal distribu-
tion. Proportions were compared with the chi-square test. Re-
sponders were compared with non-responders according to
demographic variables. For each analysis, persons with missing
information on the included variables were excluded. This was
done after the survey response. Logistic regression was used to
explore associations of ATP and shock, and whether primary or
secondary prophylactic indication had the greatest implication.
Analyses were performed as age-adjusted univariate analyses with
the 3 variables ATP, shock, and indication, and a multivariate
analysis with age, ATP, time from ICD, and indication. All
analyses were performed using SPSS software version 23.0 (SPSS
Inc, Chicago, IL, USA). A P value < .05 was considered
statistically signiﬁcant for all analyses.Ethics
The study complies with the Declaration of Helsinki, and
was approved by the Danish Data Protection Agency (j.nr.
2007-58-0015) and by the Regional Ethics Committee (j.nr.
H-4-2012-168).RESULTS
Of the 826 patients approached, 476 returned the question-
naire (response rate 57.6%), 25 returned the questionnaire but
declined to ﬁll it out, and 35 did not have a partner. Thus, a
sample of valid 415 questionnaires were analyzed (Figure 1).Sex Med 2019;7:169e176The mean age of the study population was 63.9±12.1 with a
range from 19e93 years. Participants had their ICD for a mean
of 4.9±3.8 years (range 1e21) and 38 patients had a cardiac
resynchronization therapy deﬁbrillator. Patients had a mean of
0.5±1.8 appropriate shocks (range 0e18), 0.2±1.4 inappro-
priate shocks (range 0e33), 5.1±42.4 appropriate ATP (range
0e1,021), and 0.6±5.8 inappropriate ATP (range 0e110)
(Table 1). The mean score on the total IIEF scores was
39.6±24.2 indicating a poor sexual function, and only 31% of
the population had a good sexual function according to the total
IIEF score (score 60e75). Mean scores on the other domains
were as follows: 14.5±11.4 on the Erectile Function domain,
5.6±4.3 on the Orgasmic Function domain, 6.0±2.3 on the
Sexual Desire domain, 5.6±5.6 on the Intercourse Satisfaction
domain, and 6.1±2.7 on the Overall Satisfaction domain.
The prevalence of ED of any degree as an erectile function
domain score below 25, was present in 70.5% of the patients.
The distribution of ED was as follows: 29.6% normal erectile
function, 7% mild ED, 7% mild to moderate ED, 7.5% mod-
erate ED, and 48.9% severe ED. Advancing age (continuous)
was highly associated with ED with an OR 1.11 95% CI:
1.08e1.13. When the age groups were stratiﬁed by decades
(Table 2), >90% of the patients >70 years had ED deﬁned as an
erectile function domain score <25.
When the other IIEF domains were investigated separately the
prevalence of orgasmic dysfunction was present in 57.9% of
patients, 82.8% had lowered sexual desire, 85.8% had inter-
course satisfaction problems, and 76.9% experienced problems
related to overall satisfaction and when stratifying for primary vs
secondary prophylactic indication, erectile function domain and
the total IIEF score differed signiﬁcantly in the 2 groups
(Figure 2). Age was not signiﬁcantly different between the pri-
mary prophylactic indication group and the secondary prophy-
lactic indication group (P ¼ .48).
Analysis showed that mean intercourse satisfactions scores and
mean overall satisfaction scores were statistically signiﬁcant
related to severity of ED (P < .001). Lower scores were observed
when ED severity increased (Table 3). The mean satisfaction
score in the intercourse satisfaction domain as well as the mean
scores in the overall satisfaction domain revealed that only
Table 1. Baseline variables for the participating ICD population
Variable Responders Non-responders P*
N 415 411
Age 64.4 ± 11.6 63.5 ± 12.8 .27
Time since ICD in
years
5.1 ± 3.8 4.7 ± 3.7 .11
CRTD 19 19 .99
Number of
appropriate
ATP therapies
7.8 ± 11.3 2.3 ± 58.7 .06
Number of
inappropriate
ATP Therapies
0.6 ± 5.6 0.6 ± 6.1 .90
Number of
appropriate
high-voltage
shock therapies
0.5 ± 1.7 0.44 ± 1.8 .55
Number of
inappropriate
high-voltage
shock therapies
0.2 ± 1.8 0.2 ± 1.1 .98
Primary
prophylactic
indication
188 174 .44
Secondary
prophylactic
indication
224 232
ATP ¼ antitachycardia pacing; CRTD ¼ cardiac resynchronization therapy
deﬁbrillator; ICD ¼ implanted cardioverter deﬁbrillator.
Values are n or mean±SD.
*Signiﬁcance test for responders vs non-responders using t-test for
continuous variables and chi-square test for categorical variables.
172 Palm et alpatients without ED had a mean score consistent with good
satisfaction.
When investigating the associations with ED, age-adjusted
logistic regression showed that patients with primary preven-
tion indication had a higher risk of having ED with an OR
2.06, 95% CI: 1.2e3.5 compared with patients having ICD on
secondary prevention indication. Receiving ATP from the ICD
compared with not receiving ATP was associated with ED OR
1.8, 95% CI: 1.1e3.2, orgasmic dysfunction OR 2.1, 95% CI:
1.3e3.5, lowered intercourse satisfaction OR 1.9, 95%Table 2. Prevalence and severity of erectile dysfunction in all and acc
Prevalence of erectile dysfunction n (%)
19e40 y
(n ¼ 18)
41e50
(n ¼ 34
ED severity
No ED (IIEF score >25) 16 (88.9) 20 (58.
Mild (IIEF score 22e25) 2 (11.1) 2 (5.9
Mild to moderate (IIEF score 17e21) 0 (0) 1 (2.9
Moderate (IIEF score 11e16) 0 (0) 2 (5.9
Severe (IIEF score 6e10) 0 (0) 9 (26.
ED ¼ erectile dysfunction; ICD ¼ implantable cardioverter deﬁbrillator; IIEF ¼CI: 1.0e3.8, but not lowered sexual desire and overall satis-
faction. We found no association with regard to shocks from the
ICD, neither appropriate nor inappropriate, and no association
with time from the ICD. In the multivariate analysis, ATP
remained associated to ED OR 2.1, 95% CI: 1.1e3.8, but not
indication.DISCUSSION
To our knowledge, this study is the ﬁrst to address sexual
dysfunction in a large male patient population with ICD using a
validated generic instrument that reﬂects the male deﬁnition of
sexual dysfunction. We found that sexual dysfunction was highly
prevalent in ICD patients, with all domains affected. Patients
with primary prophylactic indication suffered from a higher
amount of sexual dysfunction including ED compared with
patients having an ICD on secondary prophylactic indication.
Sexual dysfunction was adversely affected by ATP, however,
shock did not seem to have an impact.
Our ﬁndings showed that more than 69% suffered from
overall sexual dysfunction, and >70% from ED. ED increased
with increasing age. The prevalence is higher than observed at
matching age in the general population (38%),24 higher than in
an atrial ﬁbrillation population (57%)23 similar to patients with
ischemic heart disease (75%)25 though not as frequent as patients
with heart failure (89%).26 These proportions are not collected
with the same instrument, the IIEF, however, they all reﬂect the
clinical deﬁnition of male sexual dysfunction. Existing studies
examining sexual problems in patients with ICD are not directly
comparable with this present study because they use another
instrument; however, problems with erection and desire have
been reported in the studies by Berg et al10 and Steinke et al,11
who found erectile problems in 56% and 57% and desire
problems in 29% and 38%, respectively, of their population.
This is in contrast to this study, where ED was present in >70%
of participants and sexual desire dysfunction in >82%. Previous
study population samples were smaller, between 82 and up to
121 participants compared with 415 in this study. More patients
in the Berg study had an ICD for primary prophylactic pre-
vention indication 65% vs 45% in ours. Mean age in the 2
studies was 59 and 65, respectively, not differing from our study.ording to age group in ICD patients
y
)
51e60 y
(n ¼ 66)
61e70 y
(n ¼ 132)
71e80 y
(n ¼ 109)
81e93 y
(n ¼ 11)
8) 27 (40.9) 39 (29.5) 6 (5.5) 1 (9.1)
) 8 (12.1) 9 (6.8) 5 (4.6) 0 (0)
) 5 (7.6) 11 (8.3) 9 (8.3) 0 (0)
) 8 (12.1) 10 (7.6) 7 (6.4) 1 (9.1)
5) 18 (27.3) 63 (47.8) 82 (75.2) 9 (81.8)
International Index of Erectile Function.
Sex Med 2019;7:169e176
Figure 2. Percentage of patients with dysfunction or affected satisfaction by domain of the International Index of Erectile Function.
Patients were subcategorized by primary or secondary prophylactic indication. For each domain, dysfunction and affected satisfaction is
deﬁned as follows: a score of 25 for erectile function domain, a score of 8 for the orgasmic function domain, the sexual desire domain,
the overall satisfaction domain and a score of 12 for the intercourse satisfaction domain.
Sexual dysfunction in ICD patients 173A plausible explanation might be caused by the differences in the
instrument. The IIEF is an instrument reﬂecting the clinical
deﬁnition of sexual dysfunction, where the instrument used in
both the Berg study and the Steinke study reﬂected areas relating
to the ICD, such as fear of shock or fear of dying. Another reason
for low sexual desire can be related to ED. It is well known that
men with erectile problems tend to withdraw from their partner
with a decrease in sexual response as a consequence. Men with
low sexual response are more prone to have lack of sexual in-
terest/ lowered desire.27
Of the 70% of the patients experiencing ED, 50% had severe
ED, which completely prevents sexual intercourse. This is a high
proportion of patients not being able to enjoy sexual activity in
the form of sexual intercourse. It is well established that ED is
highly prevalent in both patients suffering from ischemic heart
disease and heart failure, the major patient groups receiving an
ICD, and that the causes are primarily related to atherosclerosis
but also anxiety and side effects to medication is known to have a
substantial negative impact.5 We were not able to adjust for anyTable 3. Relationship between satisfaction scores and erectile dysfun
ED severity
No ED Mild
Mean Intercourse Satisfaction Score* 12.2±2.1 9.3±2.4
Mean Overall Satisfaction Score* 8.4±1.5 7.1±1.6
*Signiﬁcant on one-way ANOVA. Trend across groups. Scores are mean±SD.
Sex Med 2019;7:169e176of the potential causes in this cohort owing to limited descriptive
data and therefore the result must be interpreted as an overall
prevalence in a relatively large population sample of ICD
patients.
The study revealed that a decrease in erectile function was
associated with a decrease in both intercourse satisfaction and
overall satisfaction, and that it was only patients without ED who
experienced good intercourse and overall satisfaction. This implies
that even patients with the mildest form of ED experience adverse
impact on sexual satisfaction. The same trend is described by
Makarem et al28 in a group of hemodialysis patients. However, in
this study, it was only overall satisfaction affected by ED and also
patients with mild ED seemed to have a good overall satisfaction.
In contrast, though not completely comparable, a study by Giraldi
et al29 found that in a randomly chosenDanish population, 11%of
men suffering from ED were unsatisﬁed with their sexual life. ED
was measured by the same instrument, the IIEF, but with a lower
cut-off score for ED of21, probably resulting in a smaller group
with ED compared with ours.ction (ED) severity
PMild to moderate Moderate Severe
8.7±2.7 4.8±4.1 0.9±2.3 < .0001
6.4±1.6 5.6±2.0 4.4±2.4 < .0001
174 Palm et alPrimary prophylactic prevention indication was associated
with more sexual dysfunction compared with patients having
ICD on secondary prophylactic indication. It has been hy-
pothesized that patients with secondary prophylactic indication
would have a larger amount of psychological distress as a result
of index event such as cardiac arrest leading to the ICD
implant30 that could have inﬂuences on sexual function, how-
ever, our data could not conﬁrm that. The majority of patients
having an ICD for primary prophylactic indication are patients
with ischemic heart disease, heart failure symptoms corre-
sponding to New York Heart Association function class II and
III despite optimal medical treatment,31 reduced ejection
fraction, which are all factors known to be associated with sexual
dysfunction.5 We have not been able to adjust for these factors
in our analysis.
We found that patients receiving ATP from the ICD experi-
enced more sexual dysfunction compared with patients not
experiencing ATP, also when adjusting for age and indication.
Many patients receiving ATP will not experience the ATP itself,
but will feel the malign arrhythmia as palpitations and dizziness,
which potentially might remind them of being chronically ill and
vulnerable, all psychological impacts associated to outcomes such
as anxiety and concerns32 which potentially might reﬂect on
sexuality as well. In a study by Hoektsra et al,33 patients with
heart failure without sexual dysfunction reported signiﬁcantly
higher emotional quality of life than those with sexual dysfunc-
tion, indicating a possible connection between psychological
outcomes and sexual dysfunction.CLINICAL IMPLICATIONS
The IIEF is an easy self-administrable validated instrument
that provides valuable information on patients’ sexual function
and it can easily be adopted in a clinical setting. Therefore, the
routine use of IIEF for diagnosing sexual dysfunction should be
considered in the ICD clinic. However, because the IIEF only
evaluates the level of different dysfunctions and not the under-
lying cause, it should not serve as a single instrument. For pa-
tients with sexual dysfunction on the IIEF, a thorough sexual and
medical history is important to plan the right treatment
addressing sexual health. Treatment suggestions could include
medical treatment with phosphodiesterase type 5 inhibitors,
adjusting cardiovascular medication, psychosocial support, or risk
factor reduction, including physical exercise.5STRENGTH AND LIMITATIONS
Self-reported outcomes are by nature subjective. However, in
this study we used the IIEF, which is recognized as the gold
standard in evaluating sexual dysfunction. The study is of a
considerable size and includes a consecutively recruited popula-
tion of ICD patients. The response rate was almost 58%, which
is relatively high compared with other studies dealing with
sexual matters.2,11 The responders seemed to be similar to thenon-responders on the included variables, although it was not
possible to analyze differences such as severity of disease, medi-
cation, and social factors. Furthermore, we were not able to
adjust for hormone levels such as testosterone that might account
for some of the sexual dysfunction measured. The major limi-
tation to the study is that we were not able to adjust for
important health variables such as vascular diseases, mental
health, and medications associated with ED, nor was quality of
the man’s relationship with his sexual partner measured.
The cross-sectional design is limited in its ability to draw valid
conclusions about ﬁrm associations or possible causality because
the presence of risk factors and outcomes are measured simulta-
neously, and there is a risk that the study is either over- or un-
derpowered because it lacks power calculation. Therefore, results
should act primarily as hypothesis-generating for further studies.CONCLUSION
Sexual dysfunction is highly prevalent in ICD patients, and it
is not limited to ED, but also affects desire, orgasm, and satis-
faction in a negative way. Primary prophylactic ICD indication
and ATP, but not shock therapy, is associated with compromised
sexual function. Knowledge about ICD patients’ sexual function
is warranted and the present results may contribute to a better
understanding of the subject. Further, this study highlights the
need for a routine screening aimed at identiﬁcation of patients
with sexual dysfunction in the ICD clinic. Moreover, this study
illustrates an unmet need for interventional studies to improve
poor sexual outcome in this patient group.
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